NCT00301405View on ClinicalTrials.gov

Open-Label Study of Thalidomide for Chronic Prostatitis/Chronic Pelvic Pain

PHASE2TerminatedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

November 30, 2006

Study Completion Date

November 30, 2006

Conditions
Chronic ProstatitisPelvic Pain
Interventions
DRUG

Thalidomide

Open label drug

Trial Locations (1)

48073

William Beaumont Hospital, Royal Oak

Sponsors

Collaborators (1)

Celgene Corporation
All Listed Sponsors
collaborator

Celgene Corporation

INDUSTRY

collaborator

William Beaumont Hospitals

OTHER

lead

Kenneth Peters, MD

OTHER